Fat-derived cells from adults with diffuse cutaneous scleroderma that are then injected under the skin of the hands led to clinically meaningful improvements in hand function, according to published data from the Phase 3 STAR I clinical trial. Comments are closed.
|
AuthorScleroderma Queensland Support Group Archives
November 2024
Categories
All
|